Table IV.
P-value (HR, 95% CI)a | ||
---|---|---|
Variable | Univariate | Multivariate |
Age | n.s. | – |
Preoperative PSA | 0.0029 (1.03, 1.00–1.060) | n.s. |
Clinical T stage | 0.001 (1.68, 1.23–2.29) | 0.009 (1.60, 1.12–2.29) |
Biopsy Gleason score | 0.002 (1.44, 1.14–1.81) | 0.005 (1.38, 1.10–1.75) |
PSA doubling time | 0.005 (2.82, 1.37–5.79) | 0.008 (2.76, 1.30–5.85) |
(>24 months, stable, 0.1–24 months) |
HR, hazard ratio; CI, confidence interval.